LENSAR, a global medical technology company specialising in advanced robotic laser solutions for cataract treatment, has announced that its technology has been used in over one million procedures.

This milestone reflects the company's commitment to providing innovative robotic laser systems that enhance surgical efficiency and outcomes in cataract surgery.

Since the introduction of its LLS cataract laser platform in 2012, LENSAR has worked closely with surgeons to refine its technology.

The development of the ALLY System marks a significant advancement in the field, offering a platform that combines robotic precision with surgeon expertise.

The ALLY System supports both standard and robotic laser cataract surgery, aiming to deliver consistent clinical improvements and better patient experiences.

As the only company currently focused on robotic laser cataract surgery, LENSAR continues to prioritise optimising premium laser cataract surgery solutions, bringing enhanced value to both surgeons and patients.

 

 

 

Source: globenewswire.com

Report Abuse